Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-09

FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Claravis (isotretinoin) from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claravis (isotretinoin)

Snippet

SUPPL AP for CLARAVIS (ISOTRETINOIN)